Anzeige
Mehr »
Mittwoch, 30.07.2025 - Börsentäglich über 12.000 News
Geheime Millionen-Käufe in Bitcoin & Altcoins - ohne Wallet, ohne Risiko? Jetzt wird's spannend
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PXUH | ISIN: FR0013470168 | Ticker-Symbol: IM11
Frankfurt
30.07.25 | 09:11
0,149 Euro
+5,30 % +0,008
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IMPLANET SA Chart 1 Jahr
5-Tage-Chart
IMPLANET SA 5-Tage-Chart
RealtimeGeldBriefZeit
0,1580,16214:10

Aktuelle News zur IMPLANET Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.07.IMPLANET Announces CFDA Approval for Its Innovative JAZZ Range in China220Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, PEA-PME eligible), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced...
► Artikel lesen
08.07.IMPLANET Announces Half-Year Revenue for 2025 up 41% to €5.8 Million846Second quarter 2025 up +71% to €3.2 millions Revenue in the United States increased by a factor of 5.4 in Q2 2025 and by 1.7x for the first half of 2025 compared to 2024 Strong first...
► Artikel lesen
24.04.IMPLANET to Co-Exhibit its Innovative Spine Solutions Alongside 8i Robotics' Next-Gen Robotic Solutions at AANS in Boston277Spine tech innovator IMPLANET will demo and display its game-changing portfolio in tandem with 8i Robotics' robot systems at Booth #1029, April 25-28, 2025 Regulatory News: At this year's American...
► Artikel lesen
14.04.Minutes of IMPLANET's Annual General Meeting Held on April 11, 2025438Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, éligible PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced...
► Artikel lesen
09.04.IMPLANET Reports Revenue of €2.58 Million in Q1 2025, Up +16%276+16% revenue growth compared to Q1 2024 Performance driven by strong export growth outside France and the United States (+42% vs. Q1 2024) Regulatory News: IMPLANET (Euronext Growth:...
► Artikel lesen
04.03.IMPLANET Reports Its 2024 Full-Year Results4702024 full-year revenue up +26% compared to fiscal year 2023 Continued strict control of operational costs throughout the period Regulatory News: IMPLANET (Euronext Growth: ALIMP,...
► Artikel lesen
IMPLANET Aktie jetzt für 0€ handeln
14.01.IMPLANET Announces 2024 Full-Year Revenue Up 26% to €9.4 Million397Continued acceleration in quarterly revenue growth since Q2 2024, with Q4 2024 reaching nearly €3.0 million, up 81% versus 2023 Strong full-year performance in the medical equipment distribution...
► Artikel lesen
06.01.IMPLANET Announces Its 2025 Financial Calendar508Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the...
► Artikel lesen
05.12.24IMPLANET Announces Financing of Around €2 Million447Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the...
► Artikel lesen
08.10.24IMPLANET announces revenue of €2.3 million as of September 30, 2024, 50% growth444Revenue for the first nine months of 2024: €6.4 million, a 11% increase compared to the same period last year First delivery of Olea equipment worth €0.5 million completed in the United...
► Artikel lesen
25.09.24elliquence and Implanet Form Partnership for US Distribution of Ultrasonic Bone Scalpel Olea in Endoscopic Spine Market457Spine tech innovators elliquence and Implanet to exhibit at NASS in Chicago, September 25-28, 2024 (elliquence LLC Booth 2419 Implanet Booth 2412) Regulatory News: elliquence LLC, specializing...
► Artikel lesen
19.09.24Implanet to Co-Exhibit Alongside 8i Robotics' Next-Gen Robotic Solutions at NASS1 booth #2412 in Chicago586Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced...
► Artikel lesen
10.09.24IMPLANET Announces Its 2024 Half-year Results553Revenue of €4.1 million in the first half of 2024 Sales force investment aimed at revitalizing the Company's presence in the United States Strict management of operational expenses...
► Artikel lesen
13 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1